WHO Ebola situation report: http://apps.who.int/ebola/ebola-situation-reports
Ebola vaccine
VSV-EBOV, first developed by the Public Health Agency of Canada, has shown 100% effectiveness in preventing EVD in a clinical trial in Guinea. A ring vaccination protocol was chosen for the trial, where some of the rings are vaccinated shortly after a case is detected, and other rings are vaccinated after a delay of 3 weeks.
UBC Tropical Medicine 